1932

Abstract

The conversion of somatic cells into pluripotent cells is transforming the way diseases are researched and treated. Induced pluripotent stem (iPS) cells' promise may soon be realized in the field of hematology, as hematopoietic stem cell transplants are already commonplace in clinics around the world. We provide a current comparison between induced pluripotent and embryonic stem cells, describe progress toward modeling hematological disorders using iPS cells, and illustrate the hurdles that must be overcome before iPS cell therapies will be available in clinics.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-050311-163324
2013-01-14
2024-04-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-med-050311-163324
Loading
/content/journals/10.1146/annurev-med-050311-163324
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error